AZURE CELL THERAPIES
Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases
AZURE CELL THERAPIES
Industry:
Biopharma Biotechnology Medical
Founded:
2024-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Status:
Active
Total Funding:
50 K CHF
Investors List
MassChallenge Switzerland
MassChallenge Switzerland investment in Non Equity Assistance - Azure Cell Therapies
FONGIT Innovation Fund
FONGIT Innovation Fund investment in Grant - Azure Cell Therapies
More informations about "Azure Cell Therapies"
Azure Cell Therapies - LinkedIn
Meet Bilal Fares, CEO of Azure Cell Therapies, who is advancing regenerative medicine with next-generation cell therapies for Parkinsonโs disease.Building on two decades of research at the ...See details»
Azure Cell Therapies Company Profile 2025: Valuation, Funding ...
Apr 26, 2024 Azure Cell Therapies General Information Description. Developer of healthcare therapies intended for Parkinson's disease. The company offers cell therapies for Parkinson's โฆSee details»
Azure Cell Therapies - Venturelab
Sep 27, 2024 Although cell therapies bring hope to solve PD by replacing lost brain neurons, current limitations in their safety, scalability and loss of efficacy remain to be addressed. We โฆSee details»
Azur Cell Therapies and Antion Biosciences get funding from
Mar 12, 2025 Azure Cell Therapies has been granted CHF 50โ000 to further their work unlocking next-generation cell therapies for this debilitating disease. Emerging from the University of โฆSee details»
Azure Cell Therapies - Company Profile - Tracxn
Feb 17, 2025 Azure Cell Therapies - Company developing innovative cell therapy solutions for the treatment of neurodegenerative diseases. Founded by Bilal Fares and Karl Krause in the โฆSee details»
Azure Cell Therapies - Drug pipelines, Patents, Clinical trials
Last update 23 Jan 2025. Azure Cell Therapies. Private Company |See details»
Azure Cell Therapies | Biopharma, Biotechnology, Medical
Azur Cell Therapies and Antion Biosciences get funding โฆ Nov 29, 2024 Azure Cell Therapies has been granted CHF 50โ000 to further their work unlocking next-generation cell therapies for โฆSee details»
Azure Cell, FireFly Fusion et Antion reçoivent le soutien du FIF
Apr 29, 2024 Azure Cell Therapies, issue de lโUniversité de Genève et dirigée par le Dr Bilal Fares, a reçu une bourse de CHF 50โ000 pour accélérer le développement de thérapies โฆSee details»
Startups developing neuron regeneration, waste-to-energy plants ...
Dec 18, 2024 Azure Cell Therapies, Jaipur Robotics, Lemna Bio, and RegCheck were selected at Venture Kick's first financial and entrepreneurial support stage. Their projects push the โฆSee details»
BILAL FARES // Azure Cell Therapies โ W.A. de Vigier Stiftung
BILAL FARES, CEO Azure Cell Therapies Regenerating neurons to defeat Parkinson's Every 9 minutes, someone is diagnosed with Parkinsonโs, a disease that destroys brain cells with no โฆSee details»
Azure Cell Therapies - VentureRadar
Unlocks next-generation cell therapies for Parkinsonโs disease. VentureRadar Research / Company Website. Associated sectors: Biotech; Similar Companies: Serum Bio-technology โฆSee details»
Azure Cell Therapies - Funding, Financials, Valuation & Investors
Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases. New. Resources. Advanced Search ... Experience the new Crunchbase, powered by โฆSee details»
Azure Cell Therapies - Products, Competitors, Financials, โฆ
Azure Cell Therapies's latest funding round is Biz Plan Competition. How much did Azure Cell Therapies raise? Azure Cell Therapies raised a total of $70K. Who are the investors of Azure โฆSee details»
Grant - Azure Cell Therapies - 2024-04-26 - Crunchbase
Apr 29, 2024 Organization Name . Azure Cell Therapies . Announced Date Apr 26, 2024; Funding Type ...See details»
Azure Cell Therapies - startup.ch
Although cell therapies bring hope to solve PD by replacing lost brain neurons, current limitations in their safety, scalability and loss of efficacy remain to be addressed. We are developing the โฆSee details»
Azure Cell Therapies - Founders and Board of Directors - Tracxn
Feb 17, 2025 Co-Founder; at . Azure Cell Therapies. View all details about the team at Azure Cell Therapies. Our Lite Plan Awaits you - Its Free! Sign up now to unlock full access to โฆSee details»
Azure Cell, FireFly Fusion and Antion receive FIF support | GGBa
Apr 29, 2024 Azure Cell Therapies, emerging from the University of Geneva and led by Dr. Bilal Fares, received a CHF 50,000 grant to enhance their development of cell therapies for โฆSee details»
Three Geneva Tech Projects awarded FIF Funding - startupticker.ch
Apr 26, 2024 Azure Cell Therapies has been granted CHF 50,000 to further their work unlocking next-generation cell therapies for this debilitating disease. Emerging from the University of โฆSee details»
Azure Cell Therapies Stock Price, Funding, Valuation, Revenue ...
Dec 18, 2024 See Azure Cell Therapies funding rounds, investors, investments, exits and more. Evaluate their financials based on Azure Cell Therapies's post-money valuation and revenue.See details»
Federal government announces support for cutting-edge, AI- and โฆ
5 days ago OmniaBio Inc. is a technology-focused, global cell and gene therapy contract development and manufacturing organization. A subsidiary of the Centre for โฆSee details»